Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
387.00    2.00 (0.52%)
Bid:
386.00
Ask:
387.50
Spread: 1.50 (0.389%)
Market Cap: £1.75b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

Acquisition

19 Dec 2007 14:25

HG Capital Trust PLC19 December 2007 The following is the text of a press release issued by HgCapital, which managesthe investment portfolio of HgCapital Trust plc alongside those of otherinstitutional clients. The Trust, which is a listed investment trust givinginvestors the opportunity to participate in all of HgCapital's investments, willinvest approximately €16.7million (£12m) in Casa Reha. HgCapital acquires Casa Reha from Advent International London, 19th December 2007: HgCapital, the European sector-focused privateequity investor, has acquired Casa Reha, one of the leading German privatenursing home groups. The transaction is subject to regulatory approval. Thecompany has been acquired from Advent International and management, both ofwhich are re-investing in the business. The value of the transaction wasundisclosed. Casa Reha, founded in 1995 by Covenant Care International is headquartered inOberursel, Germany. The first nursing home was opened in 1996. Today, Casa Rehais the country's fifth largest nursing home operator, with a nationwideportfolio of 48 homes providing around 7,000 beds. Contacts: HgCapitalPhilipp Schwalber Tel: +44 (0)20 7089 7888 Hering-Schuppener (German Press)Georg Jakobs/Dennis Bader Tel: +49 (69) 92187476 Maitland (UK Press)Peter Ogden Tel: +44 (0)20 7379 5151 Advent InternationalClaudia Werth Tel: +49 (69) 92037 114 About HgCapitalHgCapital is a private-equity investor in the European mid-market. We focus oninvestments with an enterprise value in the range of €75-750 million. Ourbusiness model combines sector specialisation with dedicated, pro-active supportto our portfolio companies as well as the corresponding management expertiseacross all phases of the investment process. HgCapital manages more than €2.7billion for some of the world's leading institutional and private investors. Ourgoal is to achieve outstanding results for our investors, management team andintermediaries. Further information on HgCapital can be found atwww.hgcapital.com. HgCapital's recent transactions in the healthcare sector include: • May 2007: sale of DocMorris to Celesio • July 2006: sale of Castlebeck to Castle Holdings Limited for £255m • June 2006: IPO of ClinPhone - market capitalisation of £94 million • June 2006: Sale of Pharma Bio-Research BV (PBR) to PRA International for £58 million • April 2006: £322 million MBO of Paragon Healthcare • September 2005: Sale of Tunstall for £220 million About Advent InternationalFounded in 1984, Advent International is one of the world's leading globalprivate equity firms, with offices in 15 countries on four continents. A drivingforce in international private equity for more than two decades, Advent hasbuilt an unparalleled global platform of over 100 investment professionalsacross Western and Central Europe, North America, Latin America and Asia. Thefirm focuses on cross-border, strategic restructuring and growth opportunitiesin five core sectors, employing a highly focused ownership approach to driveearnings improvements in portfolio companies. Since inception, Advent has raised£6 billion in private equity capital and completed more than 200 buyout andprivate equity transactions valued at over £15 billion in 35 countries. For moreinformation, visit www.adventinternational.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Aug 20238:00 amRNSHg agrees to partial sale of TeamSystem
4th Aug 20237:15 amRNSEdison issues review on HG Capital Trust (HGT)
20th Jul 20237:00 amRNSHg announces investment in Nomadia
19th Jun 20237:00 amRNSAzets Group secures investment from PAI to join Hg
18th May 20239:00 amRNSHg announces investment in GTreasury
17th May 20235:21 pmRNSResult of AGM
15th May 20237:00 amRNSQ1 2023 Report to 31 March 2023
12th May 20234:53 pmRNSBlock listing Interim Review
4th Apr 202310:04 amRNSDirector/PDMR Shareholding
3rd Apr 20233:51 pmRNSUpdate on HGT's Commitment to Hg's Saturn 3 Fund
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 202310:35 amRNSDirector/PDMR Shareholding
28th Mar 202312:24 pmRNSDirector/PDMR Shareholding
16th Mar 20232:14 pmRNSHgCapital Trust results summary with Doceo
15th Mar 202310:55 amRNSDirector/PDMR Shareholding
13th Mar 202310:51 amRNSUpdate on Silicon Valley Bank
13th Mar 20237:00 amRNSAnnual Results & Notice of Annual General Meeting
13th Mar 20237:00 amRNSAnnual Financial Report
31st Jan 20234:50 pmRNSBlock listing Interim Review
13th Dec 20227:00 amRNSHg agrees to sale of Transporeon
16th Nov 20227:00 amRNSEdison issues update on HgCapital Trust (HGT)
14th Nov 20227:00 amRNS3rd Quarter Results
1st Nov 202210:10 amRNSTotal Voting Rights
14th Oct 20227:00 amRNSTransaction in Own Shares
5th Oct 20227:00 amRNSIdeagen and ProcessMAP to Combine
4th Oct 20228:25 amRNSTrustQuay Secures Hg Investment
4th Oct 20227:00 amRNSTrustQuay Secures Hg Investment
13th Sep 20227:46 amRNSEdison issues update on HgCapital Trust (HGT)
12th Sep 20227:00 amRNSHgCapital Trust Interim Results 2022
12th Sep 20227:00 amRNSHalf-year Report
2nd Aug 20223:38 pmRNSHolding(s) in Company
20th Jul 20225:50 pmRNSHolding(s) in Company
14th Jul 20221:00 pmRNSHg announces a partial sale of Intelerad
7th Jul 20224:40 pmRNSReplacement: Director/PDMR Shareholding
6th Jul 20227:30 amRNSHg announces further investment in team.blue
5th Jul 20221:43 pmRNSDirector/PDMR Shareholding
4th Jul 20225:18 pmRNSDirector/PDMR Shareholding
28th Jun 20224:00 pmRNSNorstella announces merger agreement with Citeline
24th Jun 20227:00 amRNSHGT Board note agreement on acquisition of Ideagen
14th Jun 20227:00 amRNSHg agrees sale of MEDIFOX DAN to ResMed for US$1bn
9th Jun 20223:56 pmRNSInvestment in TigerRisk Partners
8th Jun 20227:00 amRNSHg further invests in The Access Group
17th May 20226:00 pmRNSHg agrees the sale of itm8 to Axcel
17th May 20227:00 amRNSEdison issues review on HgCapital Trust (HGT)
13th May 20224:54 pmRNSBlock listing Interim Review
10th May 20225:34 pmRNSResult of AGM
9th May 20227:00 amRNS1st Quarter Results
3rd May 20223:23 pmRNSAGM Update - Withdrawal of AGM Resolution
29th Apr 20221:38 pmRNSDirectorate Change
11th Apr 20223:00 pmRNSHg announces investment in LucaNet

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.